Our aspiration is to build the world’s most trusted and admired medical cannabis brand. As laws and regulations governing medical cannabis evolve in different jurisdictions, we are actively seeking to expand our operations to serve patients in need.
AUSTRALIA & NEW ZEALAND
In September 2016, Tilray became the first company to legally export medical cannabis products from North America to Australia for research and compassionate access purposes. In 2017, the company will ship additional products to Australia and expand distribution to New Zealand.
In 2014, Tilray began operating in Canada. Today, Tilray is the leading provider of high quality medical cannabis in the country, supplying thousands of patients in every province with consistent access to whole flower, milled blends and oils.
In June 2016, Tilray became the first company to legally export medical cannabis products from North America to Europe. In 2017, Tilray is expanding distribution of its products to new countries in Europe.
In February 2017, Tilray announced a strategic agreement to distribute Tilray products in Chile and Brazil.